Stearoyl-CoA desaturase indexes and n-6/n-3 fatty acids ratio as biomarkers of cardiometabolic risk factors in normal-weight rabbits fed high fat diets

Journal of Biomedical Science
Gabriela AlarcónSusana Jerez

Abstract

Biomarkers for cardiometabolic risk (CMR) factors would be important tools to maximize the effectiveness of dietary interventions to prevent cardiovascular diseases. Thus, the aim of this work was to analyze stearoyl-CoA desaturase (SCD) indexes and n-6/n-3 fatty acids (FA) ratio as biomarkers of CMR induced by feeding rabbits on high fat diets (HFDs). Rabbits were fed either regular diet or 18 % fat in regular diet (HFD) or 1 % cholesterol diet (HD) or diet containing 1 % cholesterol and 18 % fat (HFD-HD) during 6 weeks. Body weights (BW), blood pressure, visceral abdominal fat (VAF) and glucose tolerance test were determined. Total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), triglycerides (TG), fasting glucose (FG), and FA levels from plasma were measured. SCD indexes were calculated as product/precursor ratios of individual FA. BW was similar in all diet groups. HD increased TC, LDL-C, HDL-C, and TG. HFD increased TG, VAF and FG, and decreased HDL-C. The addition of HFD to HD joined to dyslipidemia increased VAF and FG. SCD indexes were increased and n-6/n-3 was unchanged in HD. SCD indexes were reduced and n-6/n-3 FA ratio was increased in HFD and HFD-HD. CMR ...Continue Reading

References

Jan 1, 1978·FEBS Letters·R Jeffcoat, A T James
Jan 1, 1986·Progress in Lipid Research·M L GargJ R Sabine
Jan 1, 1995·Progress in Lipid Research·J M Ntambi
May 20, 1998·Diabetes·N RudermanS Schneider
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·James M NtambiAlan D Attie
Sep 24, 2004·JAMA : the Journal of the American Medical Association·Katherine EspositoDario Giugliano
Feb 21, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Eva WarensjöBengt Vessby
Jun 3, 2006·The Journal of Clinical Investigation·Roger Gutiérrez-JuárezLuciano Rossetti
Aug 30, 2007·Diabetes Care·Parvin MirmiranFereidoun Azizi
Dec 11, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·François PaillardPhilippe Legrand
Jan 17, 2008·Progress in Lipid Research·Gerd Schmitz, Josef Ecker
Feb 10, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Dawn Fedor, Darshan S Kelley
Sep 17, 2011·Journal of Cardiovascular Pharmacology·Susana JerezMaría Peral de Bruno
Apr 18, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Jordi Mayneris-PerxachsUNKNOWN for PREDIMED Study Investigators
May 29, 2013·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Y H Lana LaiLuc Djoussé
Dec 18, 2013·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Rocco BarazzoniPierre Singer
Apr 9, 2014·Cardiology Research and Practice·Jaspinder Kaur

❮ Previous
Next ❯

Citations

Feb 16, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Gabriela AlarconSusana Jerez
Jun 1, 2018·Analytical Cellular Pathology (Amsterdam)·Dina SibouakazYasmina Benazzoug

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.